Intuitive Surgical's business model benefits from robust recurring revenues in consumables and services. Read why ISRG stock ...

Intuitive Surgical has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6.4%. The stock now trades at $491.85, marking a 9.4% gain. This was partly thanks to its ...

Intuitive Surgical's fourth-quarter revenue increased 19% year over year. Management guided for a notable deceleration in ...

In the latest close session, Intuitive Surgical, Inc. (ISRG) was down 2.76% at $479.27. The stock fell short of the S&P 500, which registered a loss of 1.52% for the day. Elsewhere, the Dow saw a ...

Intuitive Surgical (NASDAQ: ISRG) has faced challenges over the past year. President Donald Trump's aggressive tariffs are ...

Citi is making a clear statement about the health of U.S. medical technology heading into the spring: the sector’s fundamentals remain intact, even as broader market volatility has dragged down some ...

ISRG rides da Vinci 5 momentum as procedure volumes surge, global adoption expands and Ion and SP platforms boost recurring ...

Despite significant disruption from the pandemic and macroeconomic headwinds, Intuitive Surgical (NASDAQ: ISRG) has performed well over the past five years both as a company and as a stock. The ...

Intuitive (Nasdaq: ISRG) announced that it completed its acquisition of the da Vinci and Ion distribution business operated ...

Intuitive Surgical has completed the acquisition of da Vinci and Ion distribution businesses in several Southern European countries. The company has received FDA clearance for its da Vinci 5 system ...

Intuitive Surgical (ISRG) remains the robotic-assisted surgery market leader, with Q4 procedures up 18% and revenue rising 19% to $2.87 billion.

Holley Miller, of Grey Matter Marketing, discusses the early days of surgical robotics and the competition between Intuitive Surgical and Computer Motion.